论血透导管的选择(6)

国外文献

Optimalhemodialysiscatheterselection

subclavianand50internaljugularaccesses.NephrolDialTransplant1991;6:722-724

42.

TenkeP,RiedlCR,JonesGL,etal:Bacterialbio lmformationonurologicdevicesandheparincoatingaspreventivestrategy.IntJAnti-microbAgents2004;23:67-74

43.

Krafte-JacobsB,SivitCJ,MejiaR,etal:Catheter-relatedthrombosisincriticallyillchildren:Comparisonofcatheterswithandwithouthepa-rinbonding.JPediatr1995;126:50-54

44.

PierceCM,WadeA,MokQ:Heparin-bondedcentralvenouslinesreducethromboticandinfectivecomplicationsincriticallyillchildren.IntensiveCareMed2000;26:967-972

45.

Covidiencompanywebsite.Availableat:/VascularTherapy/pageBuilder.aspx?topicID 70019&breadcrumbs 81037:0,70018:0.AccessedJune24,2008

46.Carmedacompanywebsite.Availableat:/pages.asp?r_id 2208.AccessedJune24,2008

47.

TrerotolaSO,JohnsonMS,ShahH,etal:Tunneledhemodialysiscath-eters:Useofasilver-coatedcatheterforpreventionofinfection.Arandomizedstudy.Radiology1998;207:491-496

48.

BambauerR,MestresP,SchielR,etal:Largeborecatheterswithsurfacetreatmentsversusuntreatedcathetersforbloodaccess.JVascularAc-cess2001;2:97-105

49.

ChatzinikolaouI,FinkelK,HannaH,etal:Antibiotic-coatedhemodi-alysiscathetersforthepreventionofvascularcatheter-relatedinfec-tions:Aprospective,randomizedstudy.AmJMed2003;115:352-35750.Touchbrie ngs.Availableat:http://www.touchbrie /cdps/cditem.cfm?cid 5&nid 2603.AccessedJune24,2008

51.

Bardcompanywebsite.Availableat:/news/innovations/HemoSplitDialysisCatheterwithBioBlocCoating.cfm.AccessedJune24,2008

52.

GilbertRE,HardenM:Effectivenessofimpregnatedcentralvenouscathetersforcatheterrelatedbloodstreaminfection:Asystematicre-view.CurrOpinInfectDis2008;21:235-245

53.

HannaH,BenjaminR,ChatzinikolaouI,etal:Long-termsiliconecen-tralvenouscathetersimpregnatedwithminocyclineandrifampinde-creaseratesofcatheter-relatedbloodstreaminfectionincancerpa-tients:Aprospectiverandomizedclinicaltrial.JClinOncol2004;22:3163-3171

191

54.DarouicheRO,BergerDH,KhardoriN,etal:Comparisonofantimi-crobialimpregnationwithtunnelingoflong-termcentralvenouscath-eters:Arandomizedcontrolledtrial.AnnSurg2005;242:193-20055.Angiotechcompanypressrelease.Angiotech’sNovel5-FUCentralVe-nousCatheterReceivesFDA510(k)ClearanceApril17,2008.Angio-tech,Vancouver,Canada,2008Availableat:/article/pressRelease/idUS129447 17-Apr-2008 PRN20080417.AccessedJune24,2008

56.PRNewswire.960-Patientstudydemonstrateszerobloodstreamin-fectioninpatientstreatedwithAngiotech’snovel5-FUcentralvenouscatheter.Availableat:http:// /p/articles/mi_m4PRN/is_2008_March_18/ai_n24928092.AccessedJune24,2008

57.RichardIIIHM,HastingsGS,Boyd-KranisRL,etal:Arandomized,

prospectiveevaluationofthetesio,ashsplit,andopti- owhemodial-ysiscatheters.JVascIntervRadiol2001;12:431-435

58.TrerotolaSO,KrausM,ShahH,etal:Randomizedcomparisonofsplit

tipversussteptiphigh- owhemodialysiscatheters.KidneyInt2002;62:282-289

59.TalMG,PeixotoAJ,CrowleyST,etal:Comparisonofsideholeversus

nonsideholehigh owhemodialysiscatheters.HemodialysisInt2006;10:63-67

60.MareelsG,DeWachterDS,VerdonckPR:Computational uiddynam-ics:AnalysisoftheNiagarahemodialysiscatheterinarightheartmodel.ArtifOrgans2004;28:639-648

61.BeathardG:Catheterthrombosis.SeminDial2001;14:441-445

62.TwardowskiZJ,MooreHL:Sideholesatthetipofchronichemodialysis

cathetersareharmful.JVascAccess2001;2:8-16

63.WarrenS,O’ConnerD,SteinbergS:Recirculation:Auremicsyndrome-complicatingtheuseofprostheticarteriovenous stulasforhemodial-ysis.JDialysis1978;2:251-259

64.SenecalL,Saint-SauveurE,LeblancM:Blood owandrecirculation

ratesintunneledhemodialysiscatheters.ASAIOJ2004;50:94-9765.TalMG:ComparisonofrecirculationpercentageofthePalindrome

catheterandstandardhemodialysiscathetersinaswinemodel.JVascIntervRadiol2005;16:1237-1240

66.KakkosTK,HaddadGK,HaddadRK,etal:Effectivenessofanew

tunneledcatheterinpreventingcathetermalfunction:Acomparativestudy.JVascIntervRadiol2008;19:1018-1026